Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
ammonia
anticonvulsants, blood level determination of
anticonvulsants, mechanism of action of
anticonvulsants, untoward effects of
ataxia
ataxia, cerebellar
ataxic gait
catechol-o-methyltransferase inhibitor
cerebral edema
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, gold sol.curve of
coma
compliance
confusion
cop 1
creatine phosphokinase(CPK)elevated
cryoglobulinemia
deprenyl
dilantin, factors influencing metabolism of
drowsiness
electroencephalogram
electroencephalogram, abnormalities of
encephalomyelitis, postinfectious
enzyme, muscle disease
enzyme, serum
fasciculation
fatigue
fever
flu-like illness
gait disorder
headache
hepatic encephalopathy
hepatic failure
hepatitis
hepatitis C virus
hyperbilirubinemia
influenza A virus
interferon
interferon beta 1-a
interferon beta 1-b
intracranial pressure monitoring
jaundice
lactic dehydrogenase(LDH)
lethargy
leukopenia
level of consciousness, decreased
liver biopsy
liver function enzymes
lymphopenia
mononeuropathy multiplex
mortality
multiple sclerosis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
muscle biopsy
muscle cramp
muscular dystrophy
muscular dystrophy, Duchenne
nausea and vomiting
nerve biopsy
nerve conduction studies
neuropathy
neuropathy, cryoglobulinemic
neuropathy, peripheral
neuropathy, vasculitic, nonsystemic
Parkinson disease
Parkinson disease, treatment of
patient information and support
pericarditis
pleocytosis of cerebrospinal fluid
polymyositis
polyneuropathy
pregnancy, neurologic complications in
prothrombin time, prolonged
review article
Reye's syndrome
Reye's syndrome, adult
Sabin-Feldman dye test
sedimentation rate, elevated
seizure
seizure, treatment of
serum glutamic oxaloacetic transaminase
serum glutamic pyruvic transaminase
sodium valproate
sodium valproate, toxicity
thrombocytopenia
tolcapone
toxoplasma complement fixation test
toxoplasmosis, acquired
toxoplasmosis, CNS
treatment of neurologic disorder
tremor
tremor, intention
uveitis
viral infection
viral infection, CNS
weakness
weight gain
Showing articles 350 to 400 of 889 << Previous Next >>

The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004

Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004

Liver Injury Associated with the B-Interferons for MS
Neurol 62:628-631, Tremlett,H.L.,et al, 2004

Copper Deficiency Myelopathy
Arch Neurol 61:762-766, Kumar,N.,et al, 2004

B- and T-cell Markers in Opsoclonus-Myoclonus Syndrome
Neurol 62:1526-1532,1466, Pranzatelli,M.R.,et al, 2004

Stiff-Person Syndrome
The Neurologist 10:131-137, Murinson,B.B., 2004

Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy
Stroke 35:1903-1907, Leigh,R.,et al, 2004

Reversible Hyperintensity Lesion on Diffusion-Weighted MRI in Hypoglycemic Coma
Neurol 63:392-393, Aoki,T.,et al, 2004

Unilateral Putaminal CT, MR, and Diffusion Abonromalities Secondary to Nonketotic Hyperglycemia in the Setting of Acute Neurologic Symptoms Mimicking Stroke
AJNR 25:975-976, Wintermark,M.,et al, 2004

Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004

Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004

Correlating Lamotrigine Serum Concentrations with Tolerability in Patients with Epilepsy
Neurol 63:1022-1026, Hirsch,L.J.,et al, 2004

The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
JAMA 292:2237-2242, Yaffe,K.,et al, 2004

Mitoxantrone Treatment of Multiple Sclerosis
Neurol 63(Suppl 6):S28-S32, Cohen,B.A. &Mikol,D.D., 2004

Amyloid Myopathy Presenting with Distal Atrophic Weakness
Muscle Nerve 29:605-609, Smestad, C.,et al, 2004

Acute Mycoplasma Pneumoniae Infection Presenting as Cholestatic Hepatitis
J Clin Microbiol 41:514-515, Grullich, C.,et al, 2003

Hyperhomocysteinemia in Cerebral Vein Thrombosis
Blood 102:1363-1366, Martinelli,I.,et al, 2003

Tolerability of Memantine in Combination with Cholinesterase Inhibitors in Dementia Therapy
Int Clin Psychopharm 18:81-85, Hartmann,S.& Mobius, H.J., 2003

Polymyositis and Dermatomyositis
Lancet 362:971-982, Dalakas,M.C.&Hohlfeld,R., 2003

Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003

Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction
Neurol 61:1595-1599, Kim,N.K.,et al, 2003

Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003

Investigation of Risk Factors in Children with Arterial Ischemic Stroke
Ann Neurol 53:167-173,149, Ganesan,V.,et al, 2003

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003

Brain MR Imaging in Acute Hyperammonemic Encephalopathy Arising from Late-Onset Ornithine Transcarbamylase Deficiency
AJNR 24:390-393, Takanashi,J-i.,et al, 2003

POEMS Syndrome Associated with Ischemic Stroke
Arch Neurol 60:745-749, Kang, K.,et al, 2003

Memantine in Moderate-to-Severe Alzheimer's Disease
NEJM 348:1333-1341, Reisberg,B.,et al, 2003

Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients
Stroke 34:1235-1241, Alvarez-Sabin,J.,et al, 2003

Homocysteine and Risk of Recurrent Stroke
Stroke 34;1258-1261, Boysen,G.,et al, 2003

Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003

Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
NEJM 346:476-483, 466, Seshadri,S.,et al, 2002

CSF Evaluation in Primary CNS Lymphoma Patients by PCR of the CDR III IgH Genes
Neurol 58:390-396,339, Gleissner,B.,et al, 2002

Clinicopath Conf, Bilateral, Diffuse Uveal Melanocytic Proliferation, Metastatic Endometrial Carcinoma
NEJM 346:189-195, Case 2-2002, 2002

Hyperhomocysteinemia and Other Inherited Prothrombotic Conditions in Young Adults With a History of Ischemic Stroke
Stroke 33:51-56, Madonna,P.,et al, 2002

Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002

Clinicopath Conf, Hyperviscosity Syndrome Due to IgG Multiple Myeloma
NEJM 346:603-610, Case 6-2002, 2002

Homocysteine, Silent Brain Infarcts, and White Matter Lesions: The Rotterdam Scan Study
Ann Neurol 51:285-289,279, Vermeer,S.E.,et al, 2002

Diffusion-Weighted and Gradient Echo Magnetic Resonance Findings of Hemichorea-Hemiballismus Associated with Diabetic Hyperglycemia
Arch Neurol 59:448-452, Chu,K.,et al, 2002

Spontaneous Cervical Artery Dissection
Stroke 33:657-658,664, Brandt,T. &Grond-Ginsbach,C., 2002

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy
Stroke 33:862-875, Gorelick,P.B., 2002

Symptoms of B12 Deficiency Can Occur in Women of Child Bearing Age Supplemented with Folate
Neurol 58:1572-1573, Drazkowski,J.,et al, 2002

Hyperammonemic Encephalopathy in Multiple Myeloma
NEJM 346:1674-1675, Kwan,L.,et al, 2002

Giant-cell Arteritis
NEJM 347:272-278, Case 23-2002, 2002

Effects Of Admission Hyperglycemia on Mortality and Costs in Acute Ischemic Stroke
Neurol 59:67-71, Williams,L.S.,et al, 2002

Acute Confusional State Following Liver Transplantation for Alcoholic Liver Disease
Neurol 59:601-605, Buis,C.I.,et al, 2002

Admission Glucose Level and Clinical Outcomes in the NINDS rt-PA Stroke Trial
Neurol 59:669-674, Bruno,A.,et al, 2002

Out of Africa, Trypanosomiasis
NEJM 347:749-753, Sahlas,D.J.,et al, 2002

Neurological Presentation of Fabry's Disease in a 52 Year Old Man
JNNP 73:340-342, Mohanraj,R.,et al, 2002

Homocysteine and Risk of Ischemic Heart Disease and Stroke
JAMA 288;2015-2022, The Homocysteine Studies Collaboration, 2002

Urinary Tract Infection and Coma
Lancet 360:996, De Jonghe,B.,et al, 2002



Showing articles 350 to 400 of 889 << Previous Next >>